EMD-35039

Single-particle
3.3 Å
EMD-35039
3D View Gallery
Deposition: 23/12/2022
Map released: 27/12/2023
Last modified: 27/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-35039

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV2 spike protein with ACE2 decoy. 2 ACE2 decoy bound form.

EMD-35039

Single-particle
3.3 Å
EMD-35039
3D View Gallery
Deposition: 23/12/2022
Map released: 27/12/2023
Last modified: 27/12/2023
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV2 spike protein with ACE2 decoy. 2 ACE2 decoy bound form.

Deposition Authors: Kishikawa J, Hirose M , Kato T , Okamoto T
An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models.
Urano E , Itoh Y , Suzuki T, Sasaki T , Kishikawa JI , Akamatsu K , Higuchi Y , Sakai Y , Okamura T, Mitoma S , Sugihara F, Takada A, Kimura M, Nakao S, Hirose M , Sasaki T , Koketsu R, Tsuji S , Yanagida S, Shioda T , Hara E , Matoba S , Matsuura Y , Kanda Y , Arase H , Okada M , Takagi J , Kato T , Hoshino A , Yasutomi Y , Saito A , Okamoto T
(2023) Sci Transl Med , 15 , eadi2623 - eadi2623
PUBMED: 37647387
DOI: doi:10.1126/scitranslmed.adi2623
ISSN: 1946-6242